Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer.

@article{Fedele2015RecentAI,
  title={Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer.},
  author={Palma Fedele and Laura F Orlando and Paola Schiavone and Nicola Calvani and Chiara Caliolo and Annamaria Quaranta and Angelo Nacci and Saverio Cinieri},
  journal={Critical reviews in oncology/hematology},
  year={2015},
  volume={94 3},
  pages={291-301}
}
Endocrine therapy is the recommended systemic therapy for hormone receptor (HR) positive metastatic breast cancer (MBC). However so far the limited number of endocrine agents and the onset of endocrine resistance have severely limited the therapeutic options for this patients. In the last years many targeted agents have been investigated to prevent or… CONTINUE READING